• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Sucampo Pharmaceuticals Inc

+ Add to Watchlist

R3A:GR

9.368 EUR 0.012 0.13%

As of 03:07:11 ET on 11/27/2014.

Snapshot for Sucampo Pharmaceuticals Inc (R3A)

Open: 9.359 Day's Range: 9.359 - 9.472 Volume: 0
Previous Close: 9.380 52wk Range: 4.297 - 9.851 1-Yr Rtn: +64.47%

Stock Chart for R3A

No chart data available.
  • R3A:GR 9.472
  • 1D
  • 1M
  • 1Y
9.380
Interactive R3A Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for R3A

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 29.9824
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 0.3900
Est. PEG Ratio 0.3702
Market Cap (M EUR) 415.47
Shares Outstanding (M) 44.35
30 Day Average Volume 141
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for R3A

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for R3A

Sucampo Pharmaceuticals, Inc. researches and develops drugs based on protones, which are derived from functional fatty acids. The Company produces a prescription drug for the treatment of chronic idiopathic constipation.

Peter GreenleafChief Executive OfficerPeter A KienerChief Scientific Officer
Thomas J KnappExec VP/Chief Legal Ofcr/SecyMatthias AlderExec VP:Bus Dev & Licensing
More Company Profile & Key Executives for R3A

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil